NKTR - Nektar Therapeutics

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 56.97B
Enterprise Value 36.24B
Trailing P/E 9.40
Forward P/E 1-20.13
PEG Ratio (5 yr expected) 1-1.48
Price/Sales (ttm)5.58
Price/Book (mrq)3.89
Enterprise Value/Revenue 34.99
Enterprise Value/EBITDA 67.84

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2017
Most Recent Quarter (mrq)Sep 30, 2018

Profitability

Profit Margin 59.71%
Operating Margin (ttm)62.84%

Management Effectiveness

Return on Assets (ttm)34.65%
Return on Equity (ttm)79.57%

Income Statement

Revenue (ttm)1.25B
Revenue Per Share (ttm)7.53
Quarterly Revenue Growth (yoy)-81.80%
Gross Profit (ttm)278.56M
EBITDA 795.33M
Net Income Avi to Common (ttm)745.7M
Diluted EPS (ttm)4.28
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)1.42B
Total Cash Per Share (mrq)8.21
Total Debt (mrq)246.51M
Total Debt/Equity (mrq)13.77
Current Ratio (mrq)13.93
Book Value Per Share (mrq)10.34

Cash Flow Statement

Operating Cash Flow (ttm)755.36M
Levered Free Cash Flow (ttm)505.72M

Trading Information

Stock Price History

Beta (3Y Monthly) 3.74
52-Week Change 3-51.22%
S&P500 52-Week Change 32.99%
52 Week High 3111.36
52 Week Low 329.22
50-Day Moving Average 342.10
200-Day Moving Average 346.83

Share Statistics

Avg Vol (3 month) 31.97M
Avg Vol (10 day) 32.13M
Shares Outstanding 5173.08M
Float 171.74M
% Held by Insiders 10.89%
% Held by Institutions 197.32%
Shares Short (Jan 31, 2019) 419.92M
Short Ratio (Jan 31, 2019) 410.15
Short % of Float (Jan 31, 2019) 422.40%
Short % of Shares Outstanding (Jan 31, 2019) 411.51%
Shares Short (prior month Dec 31, 2018) 419.33M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 21/2
Last Split Date 3Aug 23, 2000